Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets.
Karakasis P, Theofilis P, Vlachakis PK, Korantzopoulos P, Patoulias D, Antoniadis AP, Fragakis N.
Karakasis P, et al.
Int J Mol Sci. 2024 Dec 30;26(1):209. doi: 10.3390/ijms26010209.
Int J Mol Sci. 2024.
PMID: 39796066
Free PMC article.
Review.
Emerging therapeutic strategies include antifibrotic agents targeting the renin-angiotensin-aldosterone system, novel pathways like TGF-beta signaling, and cardio-metabolic drugs like SGLT2 inhibitors and GLP-1 receptor agonists. ...
Emerging therapeutic strategies include antifibrotic agents targeting the renin-angiotensin-aldosterone system, novel pathways like T …